Exploring the relationship between the inhibition of gap junctional intercellular communication and other biological phenomena

Carcinogenesis

Volumn 21, Issue 5, 2000, Pages 1007-1011

  Rosenkranz, H S ^a   Pollack, N ^a   Cunningham, A R ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOTOXICITY; GAP JUNCTION; GENOTOXICITY; HUMAN; HUMAN CELL; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; TOXICOLOGY;

ANIMALS; CARCINOGENS; CELL COMMUNICATION; DNA; GAP JUNCTIONS; MODELS, BIOLOGICAL; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034019784     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.5.1007     Document Type: Article

References (64)

1. Trosko, J.E. and Chang, C.C. (1984) A possible mechanistic link between teratogenesis and carcinogenesis: inhibited intercellular communication. In Chu, E.H.Y., Hollaender, A. and Generoso, W. (eds) Principles of Environmental Mutagenesis, Carcinogenesis and Teratogenesis. Plenum Press, New York, NY, pp. 529-547.
2. Trosko, J.E. and Chang, C.C. (1986) Oncogene and chemical inhibition of gap junctional intercellular communication: implications for teratogenesis and carcinogenesis. In Ramel, C., Lambert, B. and Magnusson, J. (eds) Genetic Toxicology of Environmental Chemicals. Alan R. Liss Inc., New York, NY, p. 21.
3. Trosko, J.E., Chang, C.C., Upham, B. and Wilson, M. (1998) Epigenetic toxicology as toxicant-induced changes in intracellular signalling leading to altered gap junctional intercellular communication. Toxicol. Lett., 102-103, 71-78.
4. Yamasaki, H., Mesnil, M., Omori, Y., Mironov, N. and Krutovskikh, V. (1995) Intercellular communication and carcinogenesis. Mutat. Res., 333, 181-188.
5. Klaunig, J.E. and Ruch, R.J. (1990) Biology of disease. Role of inhibition of intercellular communication in carcinogenesis. Lab. Invest., 62, 135-146.
6. Oh, S.Y., Grupen, C.G. and Murray, A.W. (1991) Phorbol ester induced phosphorylation and down regulation of connexin 43 in WB cells. Biochim. Biophys. Acta, 1094, 243-245.
7. Musil, L.S. and Goodenough, D.A. (1990) Gap junctional intercellular communication and the regulation of connexin expression and function. Curr. Opin. Cell Biol., 2, 875-880.
8. Trosko, J.E., Chang, C.C., Madhukar, B.V. and Dupont, E. (1993) Oncogenes, tumor suppressor genes and intercellular communication in the Oncogeny as partially blocked ontogeny hypothesis. In Iversen, O.H. (ed.) New Frontiers in Cancer Causation. Taylor and Francis, Washington, DC, pp. 181-197.
9. Bruzzone, R., White, T.W. and Goodenough, D.A. (1996) The cellular internet: on-line with connexins. Bioessays, 18, 709-718.
10. Yamasaki, H. (1996) Role of disrupted gap junctional intercellular communication in detection and characterization of carcinogens. Mutat. Res., 365, 91-105.
11. Yamasaki, H., Mesnil, M., Omori, Y., Mironov, N. and Krutovskikh, V. (1995) Intercellular communication and carcinogenesis. Mutat. Res., 333, 181-188.
12. Guan, X., Wilson, S., Schlender, K.K. and Ruch, R.J. (1996) Gap-junction disassembly and connexin 43 dephosphorylation induced by 18β-glycyrrhetinic acid. Mol. Carcinog., 16, 157-164.
13. Jansen, L.A.M., Mesnil, M. and Jongen, W.M.F. (1996) Inhibition of gap junctional intercellular communication and delocalization of the cell adhesion molecule E-cadherin by tumor promoters. Carcinogenesis, 17, 1527-1531.
14. Jansen, L., Mesnil, M., Koeman, J. and Jongen, W. (1996) Tumor promoters induce inhibition of gap junctional intercellular communication in mouse epidermal cells by affecting the localization of connexin43 and E-cadherin. Environ. Toxicol. Pharmacol., 1, 185-192.
15. Sawey, M.J., Goldschmidt, M.H., Risek, B., Gilula, N.B. and Lo, C.W. (1996) Perturbation in connexin 43 and connexin 26 gap-junction expression in mouse skin hyperplasia and neoplasia. Mol. Carcinog., 17, 49-61.
16. Bergoffen, J., Scherer, S.S., Wang, S., Scott, M.O., Bone, L.J., Paul, D.L., Chen, K., Lensch, M.W., Chance, P.F. and Fischbeck, K.H. (1993) Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science, 262, 2039-2042.
17. Kelsell, D.P., Dunlop, J., Stevens, H.P., Lench, N.J., Liang, J.N., Parry, G., Mueller, R.F. and Leigh, I.M. (1997) Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature, 387, 80-83.
18. Britz-Cunningham, S.H., Shah, M.M., Zuppan, C.W. and Fletcher, W.H. (1995) Mutations of the connexin 43 gap junction gene in patients with heart malformations and defects of laterality. N. Engl. J. Med., 332, 1323-1329.
19. Shiels, A., Mackay, D., Ionides, A., Berry, V., Moore, A. and Bhattacharya, S. (1998) A missense mutation in the human connexin50 gene (GJA8) underlies autosomal dominant 'zonular pulverulent' cataract, on chromosome 1q. Am. J. Hum. Genet., 62, 526-532.
20. Reaume, A.G., de Sousa, P.A., Kulkarni, S., Langille, B.L., Zhu, D., Davies, T.C., Juneja, S.C., Kidder, G.M. and Rossant, J. (1995) Cardiac malformation in neonatal mice lacking connexin 43. Science, 267, 1831-1834.
21. Rosenkranz, M., Rosenkranz, H.S. and Klopman, G. (1997) Intercellular communication, tumor promotion and non-genotoxic carcinogenesis: relationships based upon structural considerations. Mutat. Res., 381, 171-188.
22. Rosenkranz, H.S., Cunningham, A.R., Zhang, Y.P., Claycamp, H.G., Macina, O.T., Sussman, N.B., Grant, S.G. and Klopman, G. (1999) Development, characterization and application of predictive-toxicology models. SAR QSAR Environ. Res., 10, 277-298.
23. National Academy of Sciences (1984) Toxicity Testing. Strategies to Determine Needs and Priorities. National Academy Press, Washington, DC.
24. Pollack, N., Cunningham, A.R., Klopman, G. and Rosenkranz, H.S. (1999) Chemical diversity approach for evaluating mechanistic relatedness among toxicological phenomena. SAR QSAR Environ. Res., in press.
25. Klopman, G. and Rosenkranz, H.S. (1994) Prediction of carcinogenicity/ mutagenicity using MULTICASE. Mutat. Res., 305, 33-46.
26. Klopman, G. and Rosenkranz, H.S. (1995) Toxicity estimation by chemical substructure analysis: the Tox II program. Toxicol. Lett., 79, 145-155.
27. Chankong, V., Haimes, Y.Y., Rosenkranz, H.S. and Pet-Edwards, J. (1985) The Carcinogenicity Prediction and Battery Selection (CPBS) method: a Bayesian approach. Mutat. Res., 153, 135-166.
28. Zhang, Y.P., Sussman, N., Macina, O.T., Rosenkranz, H.S. and Klopman, G. (1996) Prediction of the carcinogenicity of a second group of chemicals undergoing carcinogenicity testing. Environ. Health Perspect., 104 (suppl. 5), 1045-1050.
29. Macina, O.T., Zhang, Y.P. and Rosenkranz, H.S. (1998) Improved predictivity of chemical carcinogens: the use of a battery of SAR models. In Kitchin, K.T. (ed.) Carcinogenicity: Testing, Predicting and Interpreting Chemical Effects. Marcel Dekker, New York, NY, pp. 227-250.
30. Rannug, U., Sjogren, M., Rannug, A., Gillner, M., Toftgard, R., Gustafsson, J.-A., Rosenkranz, H. and Klopman, G. (1991) Use of artificial intelligence in structure-affinity correlations of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) receptor ligands. Carcinogenesis, 12, 2007-2016.
31. Liu, M., Sussman, N., Klopman, G. and Rosenkranz, H.S. (1996) Estimation of the optimal data base size for structure-activity analyses: the Salmonella mutagenicity data base. Mutat. Res., 358, 63-72.
32. Zeiger, E., Ashby, J., Bakale, G., Enslein, K., Klopman, G. and Rosenkranz, H.S. (1996) Prediction of Salmonella mutagenicity. Mutagenesis, 11, 471-484.
33. Mersch-Sundermann, V., Klopman, G. and Rosenkranz, H.S. (1996) Chemical structure and genotoxicity: studies of the SOS chromotest. Mutat. Res., 340, 81-91.
34. Mersch-Sundermann, V., Schneider, U., Klopman, G. and Rosenkranz, H.S. (1994) SOS-induction in E.coli and Salmonella mutagenicity: a comparison using 330 compounds. Mutagenesis, 9, 205-224.
35. Ashby, J. and Tennant, R.W. (1991) Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutat. Res., 257, 229-306.
36. Gold, L.S., Sawyer, C.B., Magaw, R., Backman, G.M., de Veciana, M., Levinson, R., Hooper, N.K., Havender, W.R., Bernstein, L., Peto, R., Pike, M.C. and Ames, B.N. (1984) A carcinogenic potency database of the standardized results of animal bioassays. Environ. Health Perspect., 58, 9-319.
37. Gold, L.S., de Veciana, M., Backman, G.M., Magaw, R., Lopipero, P., Smith, M., Blumenthal, M., Levinson, R., Bernstein, L. and Ames, B.N. (1986) Chronological supplement to the Carcinogenic Potency Database: standardized results of animal bioassays published through December 1982. Environ. Health Perspect., 67, 161-200.
38. Gold, L.S., Slone, T.H., Backman, G.M., Magaw, R., Da Costa, M., Lopipero, P., Blumenthal, M. and Ames, B.N. (1987) Second chronological supplement to the Carcinogenic Potency Database: standardized results of animal bioassays published through December 1984 and by the National Toxicology Program through May 1986. Environ. Health Perspect., 74, 237-329.
39. Gold, L.S., Slone, T.H., Backman, G.M., Eisenberg, S., DaCosta, M., Wong, M., Manley, N.B., Rohrbach, L. and Ames, B.N. (1990) Third chronological supplement to the Carcinogenic Potency Database: standardized results of animal bioassays published through December 1986 and by the National Toxicology Program through June 1987. Environ. Health Perspect., 84, 215-286.
40. Gold, L.S., Manley, N.B., Slone, T.H., Garfinkel, G.B., Rohrbach, L. and Ames, B.N. (1993) The fifth plot of the Carcinogenic Potency Database: results of animal bioassays published in the general literature through 1988 and by the National Toxicology Program through 1989. Environ. Health Perspect., 100, 65-135.
41. G'mez, J., Macina, O.T., Mattison, D.R., Zhang, Y.P., Klopman, G. and Rosenkranz, H.S. (1999) Structural determinants of developmental toxicity in hamsters. Teratology, 60, 190-205
42. Ghanooni, M., Mattison, D.R., Zhang, Y.P., Macina, O.T., Rosenkranz, H.S. and Klopman, G. (1997) Structural determinants associated with risk of human developmental toxicity. Am. J. Obstet. Gynecol., 176, 799-806.
43. Graham, C., Gealy, R., Macina, O.T., Karol, M.H. and Rosenkranz, H.S. (1996) QSAR for allergic contact dermatitis. Quant. Struct. Activ. Relat., 15, 224-229.
44. Rosenkranz, H.S., Zhang, Y.P. and Klopman, G. (1998) The development and characterization of an SAR model of the Draize eye irritation test. Altern. Lab. Anim., 26, 779-809.
45. Macina, O.T., Klopman, G. and Rosenkranz, H.S. (1997) Structural basis of sensory irritation. Inhalation Toxicol., 9, 465-476.
46. Graham, C., Rosenkranz, H.S. and Karol, M.H. (1997) Structure-activity model of chemicals that cause human respiratory sensitization. Regul. Toxicol. Pharmacol., 26, 296-306.
47. Rosenkranz, H.S., Matthews, E.J. and Klopman, G. (1992) Relationship between cellular toxicity, the maximum tolerated dose, lipophilicity and electrophilicity. ATLA, 20, 549-562.
48. Ekwall, B. (1980) Toxicity to HeLa cells of 205 drugs as determined by the metabolic inhibition test supplemented with microscopy. Toxicology, 17, 273-295.
49. Kirchner, L.A., Moody, R.P., Doyle, E., Bose, R. and Chu, I. (1997) The prediction of skin permeability by using physicochemical data. ATLA, 25, 359-370.
50. Miller, J.A. and Miller, E.C. (1977) Ultimate chemical carcinogens as reactive mutagenic eletrophiles. In Hiatt, H.H., Watson, J.D. and Winsten, J.A. (eds) Origins of Human Cancer. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 605-627.
51. Ames, B.N., Durston, W.E., Yamasaki, E. and Lee, F.D. (1973) Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc. Natl Acad. Sci. USA, 70, 2281-2285.
52. Potts, R.O. and Guy, R.H. (1992) Predicting skin permeability. Pharm. Res., 9, 663-669.
53. Potts, R.O. and Guy, R.H. (1995) A predictive algorithm for skin permeability: the effects of molecular size and hydrogen bond activity. Pharm. Res., 12, 1628-1633.
54. Rosenkranz, H.S., Zhang, Y.P., Macina, O.T., Mattison, D.R. and Klopman, G. (1998) Human developmental toxicity and mutagenesis. Mutat. Res., 422, 347-350.
55. Cohen, M.D., Schook, L.B., Oppenheim, J.J., Freed, B.M. and Rodgers, K.E. (1998) Symposium overview: alterations in cytokine receptors by xenobiotics. Toxicol. Sci., 48, 163-169.
56. Kinzel, V., Kreibich, G., Hecker, E. and Süss, R. (1979) Stimulation of choline incorporation in cell cultures by phorbol derivatives and its correlation with their irritant and tumor-promoting activity. Cancer Res., 39, 2743-2750.
57. Fischer, S.M., Baldwin, J.K., Jasheway, D.W., Patrick, K.E. and Cameron, G.S. (1988) Phorbol ester induction of 8-lipoxygenase in inbred SENCAR (SSIN) but not C57BL/6J mice correlated with hyperplasia, edema, and oxidant generation but not ornithine decarboxylase induction. Cancer Res., 48, 658-664.
58. Gschwendt, M., Kittstein, W., Fürstenberger, G. and Marks, F. (1984) The mouse ear edema: a quantitatively evaluable assay for tumor promoting compounds and for inhibitors of tumor promotion. Cancer Lett., 25, 177-185.
59. Sorg, B., Schmidt, R., Pecar, S., Schara, M. and Hecker, E. (1988) Spin-labeled phorbol esters and their interactions with cellular membranes. III. Skin irritant and tumor-promoting activities of spin-labeled phorbol-12, 13-diesters and relationships to their particular structures. Carcinogenesis, 9, 1829-1834.
60. Criswell, K.A. and Loch-Caruso, R. (1995) Lindane induced elimination of gap junctional communication in rat uterine myocytes is mediated by an arachidonic acid-sensitive cAMP-independent mechanism. Toxicol. Appl. Pharmacol., 135, 127-138.
61. Ames, B.N. and Gold, L.S. (1990) Chemical carcinogenesis: too many rodent carcinogens. Proc. Natl Acad. Sci. USA, 87, 7772-7776.
62. Cohen, S.M. and Ellwein, L.B. (1990) Cell proliferation in carcinogenesis. Science, 249, 1007-1011.
63. Cohen, S.M. and Ellwein, L.B. (1991) Genetic errors, cell proliferation and carcinogenesis. Cancer Res., 51, 6493-6505.
64. Preston-Martin, S., Pike, M.C., Ross, R.K., Jones, P.A. and Henderson, B.E. (1990) Increased cell division as a cause of human cancer. Cancer Res., 50, 7415-7421.